$120.85$150.99
Prepare to embark on a sensory journey with the Bosco Apple, a fruit that transcends the ordinary and promises an unparalleled taste experience. These apples are nothing short of nature’s masterpiece, celebrated for their distinctive blend of flavors and their captivating visual allure.
Availability: In Stock
₹112
INTRODUCTION CABAZA 400MG contains Pentoxifylline which belongs to the group of medicines called Peripheral vasodilators. It is used in the treatment of peripheral vascular disease (poor blood circulation to the arms and legs) and intermittent claudication (pain while walking or at rest due to...
CABAZA 400MG contains Pentoxifylline which belongs to the group of medicines called Peripheral vasodilators. It is used in the treatment of peripheral vascular disease (poor blood circulation to the arms and legs) and intermittent claudication (pain while walking or at rest due to poor circulation to the legs). Peripheral vascular disease (PVD) is a blood circulation disorder that causes the blood vessels outside of your heart and brain to narrow, block, or spasm and it occurs mostly in legs. Symptoms include leg weakness and numbness, painful cramp in hips, thighs or calf muscles after activities like walking or climbing stairs and cool skin around lower leg or foot.
Pentoxifylline works by decreasing the thickness (viscosity) of blood and allowing it to pass more easily through the blood vessels. This effect is useful in peripheral vascular disease, where the blood vessels in the arms and legs are narrowed.
CABAZA 400MG is not recommended for use in patients who have heart problems or recently had a heart attack, severe palpitations (very fast and uneven heartbeats), stroke with bleeding in the brain (cerebral hemorrhage), and bleeding in the eye (retinal hemorrhage). Before taking CABAZA 400MG inform your doctor if you are pregnant or breast-feeding. It is not recommended for use in children and adolescents (under 18 years of age) and it should be used with caution in elderly patients (aged 65 years and above). The most common side effects of taking CABAZA 400MG are bloating, diarrhea, flushing, nausea, stomach discomfort, and vomiting. Contact your physician if any of the symptoms worsen.
Treats:
CABAZA 400MG works by decreasing the thickness (viscosity) of blood and allowing it to pass more easily through the blood vessels. This effect is useful in peripheral vascular disease, where the blood vessels in the arms and legs are narrowed.
Take CABAZA 400MG as advised by your physician. Swallow the medicines with a glass of water. Do not crush or chew the medicine. Your physician will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Stop taking CABAZA 400MG and contact your doctor immediately if you experience any of the following side effects:
Nausea or vomiting:
Take this medicine with, or just after meals. Stick to simple meals. Avoid eating oil-rich or spicy foods. Contact your doctor if nausea and vomiting did not improve.
Diarrhoea:
Drink lot of fluids, such as water or fruit juices to keep you hydrated. Do not take any medicine on your own for treating diarrhea. Contact your doctor if your diarrhoea did not improve.
Stomach pain:
Try to take rest and relax. Eat and drink slowly or try to have smaller and frequent meals. Keep a heat pad on your stomach. If the symptom does not improve, contact your doctor.
Dizziness:
Try to rest and relax. Get enough sleep. Avoid driving or operate any machines while you are feeling dizzy. Do not drink alcohol, as it can aggravate your dizziness. Contact your doctor if your dizziness did not improve.
CABAZA 400MG is not recommended for use in pregnant women. Consult your doctor before taking CABAZA 400MG.
CABAZA 400MG should be used in breast-feeding women only if considered clearly necessary as it may pass through breast milk. Consult your doctor before taking CABAZA 400MG.
Do not drive or operate any machines if you feel dizzy after taking CABAZA 400MG.
CABAZA 400MG should be used with caution in patients having kidney problems and your doctor may initiate the treatment with the lowest effective dose. Consult your doctor before taking CABAZA 400MG.
CABAZA 400MG should be used with caution in patients having liver problems. Consult your doctor before taking CABAZA 400MG.
Do not take CABAZA 400MG if you are allergic to pentoxifylline or other similar medicines such as theophylline or aminophylline, caffeine, or theobromine or any of the other ingredients of this medicine.
CABAZA 400MG is not recommended for use in patients having heart problems, severe palpitations or had heart attack recently. It should be used with caution in patients with hardening or narrowing of the arteries that supply blood to the heart. Consult your doctor before taking CABAZA 400MG.
CABAZA 400MG is not recommended for use if you:
Before taking CABAZA 400MG, inform your doctor if you:
Use in pediatrics:
CABAZA 400MG is generally not suitable for use in children and adolescents under 18 years of age. Contact child’s doctor for advice.
Use in geriatrics:
CABAZA 400MG should be used with caution in elderly patients (aged 65 years and above). Usually, the treatment will be initiated with the lowest effective dose depending upon kidney function and your doctor may monitor your kidney function throughout treatment with CABAZA 400MG. Consult your doctor before taking it.
A. Drug-Drug interactions:
Before taking CABAZA 400MG, inform your doctor if you are taking any of the following medicines:
Overdosage:
If you or anyone else accidentally take too much of CABAZA 400MG, consult your doctor immediately or visit the nearby hospital. The symptoms of overdosage are low blood pressure, feeling sleepy, fits (seizures), or uneven heartbeat.
Drug | : |
Pentoxifylline |
Pharmacological Category | : |
Peripheral vasodilators |
Therapeutic Indication | : |
Peripheral vascular disease and intermittent claudication |
Dosage Forms | : |
Tablet |
Can I stop taking CABAZA 400MG if I feel better?
No, you should not stop taking CABAZA 400MG without the advice of your doctor. After feeling better, if stopped taking suddenly by your own, it may increase the risk of pain to recur and become even worse. Consult your doctor if you feel better or want to stop.
What is the use of CABAZA 400MG?
CABAZA 400MG is used to treat peripheral vascular disease (poor circulation to the arms and legs) and intermittent claudication (pain on walking or at rest caused by poor circulation to the legs). Contact your doctor before taking CABAZA 400MG.
What are the symptoms of overdosage of CABAZA 400MG?
The symptoms of overdosage are low blood pressure, feeling sleepy, fits (seizures), or uneven heartbeat. If you or anyone else accidentally take too much of CABAZA 400MG, consult your doctor immediately or visit the nearby hospital.
When not to use CABAZA 400MG?
CABAZA 400MG is not recommended for use in patients with allergic history to pentoxifylline, other similar medicines such as theophylline or aminophylline, caffeine, theobromine, during pregnancy and who have heart problems or recently had a heart attack, severe palpitations (very fast and uneven heartbeats), stroke with bleeding in the brain (cerebral hemorrhage), bleeding in the eye (retinal haemorrhage), and including children. Contact your doctor before taking CABAZA 400MG.
Is it safe to take CABAZA 400MG in patients having diabetes?
The effect of medicines used to treat diabetes (such as metformin or insulin) may alter if taken along with CABAZA 400MG. Before taking CABAZA 400MG inform your doctor if you are taking medicines including prescription medicines, OTC drugs, vitamins and herbal supplements.
1. Thomas Eschenhagen. Treatment of Ischemic Heart Disease. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 13th Edition. New York McGraw Hill Medical 2018. Page – 489-506.
2. E. Ernst. Pentoxifylline for Intermittent Claudication: A Critical Review. Journal of Angiology. May 1994. [Accessed on 8th June 2022] https://journals.sagepub.com/doi/10.1177/000331979404500502
3. Pavan Annamaraju, Krishna M. Baradhi. Pentoxifylline. NIH. National Library of Medicine, National center for biotechnology information. May 2022 [Accessed on 8th June 2022] https://www.ncbi.nlm.nih.gov/books/NBK559096/
4. Sanofi S.r.l. Electronic Medicines Compendium (EMC). [Revised in September 2021]. [Accessed on 8th June 2022] https://www.medicines.org.uk/emc/files/pil.909.pdf
5. Sanofi-Aventis. US Food and Drug Administration. [Revised in July 2010]. [Accessed on 8th June 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018631s039lbl.pdf